Drugs company makes false claims over bedwetting drug

BMJ 2002; 324 doi: (Published 05 January 2002) Cite this as: BMJ 2002;324:9
  1. Mark Gould
  1. London

    A pharmaceutical company has been censured for making “falsely optimistic” claims about the success rate of one of its products in treating bedwetting in children.

    The Prescription Medicines Code of Practice Authority, which administers the pharmaceutical industry's code of conduct, has ordered Ferring Pharmaceuticals to withdraw literature claiming that up to 71% of patients achieve long term dryness using desmopressin.

    Community paediatrician Dr Delia Elliott from the Scott Hospital in Plymouth, Devon, wrote to the BMJ in March 2001 …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription